The US Food and Drug Administration has given the green light for a non-prescription version of BlueStar, WellDoc’s mobile diabetes management platform.
Through this 510(k) class II clearance, WellDoc will now offer BlueStar and BlueStar Rx, allowing the company to offer the product through more channels. Both versions analyze diabetes data entered by the patient, comparing past data trends to...
WellDoc announced today a partnership with the American Association of Diabetes Educators (AADE), a professional membership organization of over 14,000 diabetes educators. WellDoc will incorporate educational content from AADE into its FDA-cleared, reimburseable BlueStar system for diabetes management.
"We were able to build a curriculum that will be able to be delivered in a contextually guided...
It’s been a busy week for Fitbit. The San Francisco-based wearable company announced four different partnerships, three of which are integrations with the Works with Fitbit ecosystem.
Habit, the Campbell’s Soup-backed personalized nutrition startup that uses data from genetic tests and individual’s health and fitness goals to create tailored diet and exercise plans, will now incorporate Fitbit...
